SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): July 27, 2004
ANTARES PHARMA, INC.
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction
|(Commission File Number)|| |
|707 Eagleview Boulevard, Suite 414, Exton, PA||19341|
|(Address of Principal Executive Offices)||(Zip Code)|
Registrants telephone number, including area code: (610) 458-6200
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events
On July 27, 2004, Antares Pharma, Inc. issued a press release regarding the appointment of Jack E. Stover to the position of President and Chief Operating Officer (COO). A copy of the press release is furnished as Exhibit 99.1 hereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|Date: July 27, 2004||ANTARES PHARMA, INC.|
/s/ Lawrence M. Christian
|Lawrence M. Christian|
|Chief Financial Officer|
|99.1||Press Release issued July 27, 2004|